Research & Development

BIRD Energy to invest $7.5 Million in Cooperative Israel-U.S. Clean Energy Projects

BIRD Energy | Press Release

The total value of the approved projects is $17.4 million in the areas of Batteries, Electric Aircraft, Fuel Cells, Electric Vehicles, Natural Gas, Wind Energy and Energy Efficiency The U.S. Department of Energy (DOE) and Israel’s Ministry of Energy (MoE) along with the Israel Innovation Authority have selected eight clean energy projects to receive $7.15 million under the Binational Industrial …

BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment

NEW JERSEY BUSINESS MAGAZINE

North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia. BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan …

Hackensack Meridian CDI, Merck to Collaborate on COVID-19 Research

New Jersey Business Magazine

The collaborative work aims to find drugs to treat the pandemic The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19. The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic. “The CDI was started less than a year ago to provide dynamic research …

BD Launches Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

NEW JERSEY BUSINESS MAGAZINE

BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …

PTC Therapeutics taps experimental cancer drug for new COVID-19 trial

Ben Adams | Fierce Biotech

PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19. The biopharma, which has been focused on rare diseases, is tapping its early-stage cancer drug, currently in a test for certain leukemias, to see whether it can help patients afflicted with the disease. It is any day now kick-starting a phase 2/3 trial …

New Jersey Solutions For Cell And Gene Development and Manufacturing

Louis Garguilo | Outsourced Pharma

New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …

China-Based WuXi Biologics Selects Cranbury, New Jersey for Third U.S. Clinical Manufacturing Campus

Area Development News Desk | Area Development

WuXi Biologics, a China-based global company with leading open-access biologics technology platforms, signed a 10-year lease for a clinical manufacturing facility in Cranbury, New Jersey. This news follows WuXi Biologics’ recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab …

World’s First SARS-CoV-2 Serology Test Detects Neutralizing Antibodies Without Containment Facility or Specimen

HospiMedica

Researchers have developed the world’s first serological coronavirus detection system that allows for rapid detection of neutralizing antibodies (NAbs) present in the serum of COVID-19 patients without the need for live biological materials and biocontainment facility. GenScript Biotech Corporation (Piscataway, NJ, USA), Duke-NUS Medical School, and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR) …

Molex opens of new optical R&D facility in New Jersey

Evaluation Engineering

LISLE, IL—Molex has announced the grand opening of a new research and development facility in Bridgewater, NJ. The building completion represents a significant investment by Molex in the future of optical wavelength solutions for telecommunications networks. Bridgewater Township Mayor Dan Hayes, Kathleen Coviello, vice president of technologies and life sciences investments, New Jersey Economic Development Authority (NJEDA) and Clark Smith, NJEDA senior …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Catherine Scangarella
Chief Business Development Officer